We found that the most frequently altered genes in metastatic ccRCC were VHL (47%), BAP1 (24%), TOP1 (18%), and SNCAIP (18%) in metastatic patients (Figure 1(a)). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.